Literature DB >> 10940582

Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro.

L Orfila1, M Rodríguez, T Colman, M Hasegawa, E Merentes, F Arvelo.   

Abstract

The cytotoxicity of two protoberberine alkaloids: berberine and lincangenine, their 8-hydroxy-7,8-dihydro-derivatives and tetrahydroprotoberberine:thaicanine, was evaluated. The cellular responses through the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] (MTT) method were measured in Hela (uterus carcinoma), SVKO3 (ovary carcinoma), Hep-2 (larynx carcinoma), primary culture from mouse embryon, and human fibroblast cells at the concentration: 10-1000 ppm (microg/ml) for 24 h. Berberine showed the highest cytotoxicity among the compounds tested, giving LC50 values for all cell lines at the concentration of 10 ppm. The results indicated that the cytotoxicity was notably decreased by structural changes, i.e. by modulation of the planarity caused by the introduction of hydroxyl group at C-8 and concomitant saturation of double bond between N-C8 in protoberberine molecules. In the case of berberine, the cytotoxic effect changed from 98.8 (berberine) to 39% for 8-hydroxydihydroberberine at the concentration of 100 ppm in Hela cells line. The same effect was observed with lincangenine and 8-OH-lincangenine (cytotoxicities 70 and 25%, respectively, at 1000 ppm in SVKO3 cells). On the other hand, these compounds showed a low selectivity for the different human cancer cell lines tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940582     DOI: 10.1016/s0378-8741(00)00177-x

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  A new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway.

Authors:  Eun Ryoung Jang; Minsook Ryu; Jeong Eun Park; Jung-Ho Kim; Jong-Soo Lee; Kiwon Song
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

2.  Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.

Authors:  Priyanka Bhatnagar; Manisha Kumari; Richa Pahuja; A B Pant; Y Shukla; Pradeep Kumar; K C Gupta
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

3.  Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model.

Authors:  Viktor Kettmann; Daniela Kost'álová; Hans-Dieter Höltje
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

4.  Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects.

Authors:  Bhupendra Mistry; Rahul V Patel; Young-Soo Keum; Doo Hwan Kim
Journal:  Saudi J Biol Sci       Date:  2015-09-05       Impact factor: 4.219

5.  Berberine inhibited the growth of thyroid cancer cell lines 8505C and TPC1.

Authors:  Kyoung Sik Park; Jong Bin Kim; Jaeman Bae; Seo-Young Park; Hyeon-Gun Jee; Kyu Eun Lee; Yeo-Kyu Youn
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

6.  Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium.

Authors:  Marta Cernáková; Daniela Kost'álová; Viktor Kettmann; Miriam Plodová; Jaroslav Tóth; Ján Drímal
Journal:  BMC Complement Altern Med       Date:  2002-02-19       Impact factor: 3.659

7.  Synergistic antifungal activity of berberine derivative B-7b and fluconazole.

Authors:  Li Ping Li; Wei Liu; Hong Liu; Fang Zhu; Da Zhi Zhang; Hui Shen; Zheng Xu; Yun Peng Qi; Shi Qun Zhang; Si Min Chen; Li Juan He; Xin Ju Cao; Xin Huang; Jun Dong Zhang; Lan Yan; Mao Mao An; Yuan Ying Jiang
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.